Giant Biogene Holding Co., Ltd. (2367.HK) HKSE

38.22

+0.34(+0.90%)

Updated at December 05 11:59AM

Currency In HKD

Valuation

Market Cap46.92B
Enterprise Value42.9B
P/E Ratio16.05
PEG Ratio1.96
Price/Sales Ratio6.01
Price/Book Ratio3.96
Enterprise/Revenue4.88
Enterprise/EBITDA11.47

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.37
Operating Margin0.42

Management Effectiveness

Return On Assets0.2
Return On Equity0.28

Income Statement

Revenue5.54B
Revenue/Share5.84
Gross Profit4.55B
EBITDA2.31B
Net Income2.06B
Diluted EPS2.06

Balance Sheet

Total Cash8.86B
Total Cash/Share6.64
Total Debt6.95M
Total Debt/Equity0
Current Ratio4.87
Book Value Per Share8.78

Price History

52-Week Change-21.84
52-Week High87.1
52-Week Low35.14
Moving Average 50 Days43.07
Moving Average 200 Days59.09

Statistics

Average Volume12.99M
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.19
Trailing Annual Dividend Yield3.42
Payout Ratio0.4
Last Split FactorN/A
Last Split DateN/A